Qool Therapeutics, Inc.

Qool Therapeutics, Inc.

Qool Therapeutics, Inc.

Overview
Date Founded

2005

Headquarters

1455 Adams Drive Suite 2014 MENLO PARK CA 94025

Type of Company

Private

Industries

Biotechnology
Holding Companies

Company Description

Qool Therapeutics, Inc. develops non-invasive temperature management therapies to induce therapeutic hypothermia. The company was founded by Amir Belson in 2005 and is headquartered in Menlo Park, CA.

Executives & Employees

President, Chief Executive Officer & Director

Director & Chief Technology Officer

Board of Directors

Founder at Auris Surgical Robotics, Inc.

Chief Financial Officer at PROCEPT BioRobotics Corp.

Founder at ZipLine Medical, Inc.

President, Chief Executive Officer & Director at Qool Therapeutics, Inc.

Former Vice President, Operations at Nellcor, Inc.

Executive Chairman at Tenaxis Medical, Inc.

Paths to Qool Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Qool Therapeutics, Inc.
Recent Transactions
Details Hidden

Qool Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Qool Therapeutics, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onQool Therapeutics, Inc. raised money in a private placement transaction

Investors
Details Hidden

Founded in 1980, WTI has provided over $3 billion of debt and equity capital to technology and life science companies ranging from early-stage private companies to publicly-traded companies.

Details Hidden

Zhongji Holdings Co. Ltd. is a private company headquartered in Beijing,, focused on investors,.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Qool Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Qool Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Qool Therapeutics, Inc..